A multiplex real-time molecular diagnostic test for screening SARS-CoV-2 (which causes COVID-19) in accordance to WHO and CDC recommendation whereby several genes are used for positive diagnosis.Benefits<ul><li>Fast:&nbsp;2.5&nbsp;hours from sample to result.&nbsp;</li><li>Flexible:&nbsp;Includes internal control (IC) for monitoring of potential PCR inhibitions.</li><li>Convenient:&nbsp;Easy reaction setup and result analysis.</li><li>Highly Informative:&nbsp;Use of several genes for positive diagnosis.</li></ul>Test per kit:100Compatible Instrument:<ul><li>Bio-Rad (CFX96)</li><li>LineGene 9600 Series</li><li>QuantStudio 5</li></ul>Certifications Obtained<ul><li>For European Market: CE</li><li>For Malaysia Market: MDA</li></ul>

RT-PCR

Medical Innovation Ventures (Mediven®) is a fast-growing diagnostics company based in Malaysia developing the GenoAmp®&nbsp;and ProDetect®&nbsp;series of products.

GenoAmp® Real-Time RT-PCR SARS-CoV-2

About GenoAmp® Real-Time RT-PCR SARS-CoV-2